Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Trogarzonon Dec 16, 2022 10:02am
65 Views
Post# 35175521

RE:RE:RE:RE:RE:RE:RE:Completely unprepared for this outcome

RE:RE:RE:RE:RE:RE:RE:Completely unprepared for this outcomeDid came out like It did not work and it was toxic.. but we'll try something else... at the beginning of the tax loss season, in a market correction and afetre having bullish signs and anakyst reports... That is pure Theror technology material  followed by ambulance chasors, cowboy shorts and option deadlines... what else could you ask for.  It's enough to cry for.  Waiyting for tax loss to end patiently, for shorts to get another better idea and for the company to announce a Plan,  It better be good and convincing because they will be forced by major shareholder to create value by cutting cost and beginning to look for another business model.
<< Previous
Bullboard Posts
Next >>